For the Quarter Ending March 2026
Metronidazole Prices in North America
- In United States, the Metronidazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Consumer Price Index increased 3.3% and Producer Price Index rose 4.0% year-over-year in March 2026.
- Retail sales grew 4.0% year-over-year and the domestic Manufacturing Index expanded during March 2026.
- Industrial production grew 0.7% year-over-year and unemployment remained stable at 4.3% in March 2026.
- The Metronidazole Demand Outlook remained robust as hospital procurement of essential antibiotics sustained consumption in March 2026.
- The Metronidazole Production Cost Trend increased as ethylene oxide and ammonia feedstock prices surged in Q1 2026.
- Henry Hub natural gas spot prices spiked significantly, elevating energy-intensive synthesis costs in early March 2026.
- The Metronidazole Price Forecast reflected upward pressure as domestic supply buffers narrowed in early March 2026.
Why did the price of Metronidazole change in March 2026 in North America?
- Ethylene oxide feedstock costs for metronidazole production surged decisively upward in early March 2026.
- Maintenance at a major regional facility temporarily tightened ethylene oxide flows in Q1 2026.
- Robust downstream pharmaceutical demand and steady hospital procurement sustained metronidazole consumption through March 2026.
Metronidazole Prices in APAC
- In China, the Metronidazole Price Index remained stable quarter-over-quarter in Q1 2026, balancing rising costs and ample supply.
- The Metronidazole Demand Outlook remained neutral as the Consumer Price Index rose 1.0% in March 2026.
- The Metronidazole Production Cost Trend faced upward pressure as the Producer Price Index increased 0.5% in March 2026.
- The Manufacturing Index expanded in March 2026, reflecting strong industrial activity for pharmaceutical formulation and synthesis.
- Industrial production grew 5.7% in March 2026, ensuring ample bulk active pharmaceutical ingredient supply for metronidazole.
- Retail sales grew slowly by 1.7% in March 2026, reducing discretionary veterinary metronidazole purchases across the market.
- The unemployment rate reached 5.4% in March 2026, constraining household budgets for specialized topical metronidazole applications.
- Consumer confidence hit 91.6 in February 2026, prompting a flat Metronidazole Price Forecast as buyers prioritized cost-savings.
- Ammonia imports plummeted between January and February 2026, tightening external supply channels for critical metronidazole feedstocks.
Why did the price of Metronidazole change in March 2026 in APAC?
- Raw chemical materials purchasing prices declined in February 2026, easing overall metronidazole production cost pressures.
- Domestic natural gas production grew steadily between January and February 2026, providing stable energy baselines.
- Crude oil processing volumes maintained growth in January and February 2026, ensuring stable feedstock supplies.
Metronidazole Prices in Europe
- In Germany, the Metronidazole Price Index rose quarter-over-quarter in Q1 2026, driven by surging petrochemical costs.
- The Metronidazole Production Cost Trend increased in March 2026 as European ethylene feedstock costs surged.
- Consumer inflation reached 2.7% in March 2026, increasing operational utility costs for Metronidazole API synthesis.
- Producer prices declined by -0.2% in March 2026, easing some upstream precursor pressures for manufacturers.
- The Manufacturing Index expanded in March 2026, ensuring steady pharmaceutical processing activity and supply fluidity.
- Industrial production remained stagnant at 0.0% in February 2026, reflecting flat baseline chemical manufacturing activity.
- Retail sales grew 0.7% in February 2026, supporting steady consumer purchasing power for prescription medications.
- A 4.2% unemployment rate in February 2026 sustained the Metronidazole Demand Outlook in general healthcare.
- Negative consumer confidence at -24.7 in March 2026 reduced demand for discretionary dermatological and veterinary formulations.
- The Metronidazole Price Forecast remained elevated in Q1 2026 as global energy markets experienced supply disruptions.
Why did the price of Metronidazole change in March 2026 in Europe?
- Brent crude oil prices surged in Q1 2026, severely impacting downstream chemical production costs.
- European petrochemical input costs spiked in March 2026 due to severe geopolitical supply shocks.
- The Global Petrochemical Index surged in March 2026, reflecting broad increases in chemical manufacturing expenses.
For the Quarter Ending December 2025
Metronidazole Prices in North America
- In the United States, the Metronidazole Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Metronidazole production costs increased in Q4 2025, as US biopharmaceutical companies faced rising manufacturing expenses.
- The Metronidazole demand outlook was supported by a dynamic life sciences market in Q4 2025.
- Consumer Price Index increased 2.7% year-over-year in December 2025, raising Metronidazole raw material costs.
- Producer Price Index rose 3.0% year-over-year in November 2025, indicating elevated input costs for producers.
- Industrial production expanded 2.0% year-over-year in December 2025, supporting Metronidazole supply chain stability.
- Retail sales increased 3.3% year-over-year in November 2025, indirectly bolstering Metronidazole demand.
- US manufacturing sector growth softened in December 2025 due to weakening new orders and diminished export demand.
- Natural gas prices softened in October 2025, but a December 2025 cold snap boosted US spot prices.
Why did the price of Metronidazole change in December 2025 in North America?
- Rising input costs, with CPI up 2.7% in December 2025, increased Metronidazole production expenses.
- US biopharmaceutical companies faced higher manufacturing costs in Q4 2025, impacting Metronidazole pricing.
- Softening US manufacturing growth and declining export orders in December 2025 influenced demand.
Metronidazole Prices in Europe
- Germany's Metronidazole Price Index faced downward pressure in Q4 2025, as producer prices declined 2.5% year-over-year.
- Metronidazole production costs decreased in Q4 2025, driven by a 2.5% year-over-year decline in producer prices.
- Metronidazole demand outlook remained cautious in Q4 2025, with consumer confidence significantly declining in December 2025.
- Metronidazole price trends in Q4 2025 reflected stable to lower movements, influenced by a contracting manufacturing index.
- Industrial production in Germany grew 0.8% year-over-year in October 2025, supporting Metronidazole supply.
- Energy feedstock costs for Metronidazole production saw European natural gas prices decline significantly by end of 2025.
- Firm acetaldehyde inventory in November 2025 influenced production, while German exports increased in October 2025.
- Germany's unemployment rate reached 6.2% in December 2025, indicating a challenging economic environment.
- Retail sales in Germany increased 1.1% year-over-year in November 2025, providing a stable economic backdrop.
Why did the price of Metronidazole change in December 2025 in Europe?
- German producer prices declined 2.5% year-over-year in December 2025, reducing Metronidazole manufacturing costs.
- Contracting manufacturing index in December 2025 signaled weaker industrial activity, impacting Metronidazole sentiment.
- European natural gas prices declined by end of 2025, easing energy-related production cost pressures.
Metronidazole Prices in APAC
- In China, the Metronidazole Price Index fell in Q4 2025, influenced by declining producer prices and subdued consumer demand.
- Metronidazole production costs were impacted by a 1.9% decline in producer prices in December 2025, despite elevated natural gas costs.
- Metronidazole demand was supported by market recovery in October 2025 and rapid pharmaceutical industry growth in 2025.
- Industrial production expanded by 5.2% in December 2025, with the manufacturing index also expanding.
- China's goods trade volumes strengthened in 2025, with robust export growth supporting Metronidazole trade flows.
- Elevated natural gas feedstock costs in Q4 2025, driven by high LNG spot prices, impacted production expenses.
- Weak consumer spending (CPI 0.8%, retail sales 0.9%) in December 2025 limited Metronidazole pricing power.
- The urban unemployment rate stood at 5.1% in December 2025, reflecting some economic slack.
Why did the price of Metronidazole change in December 2025 in APAC?
- Producer Price Index fell by 1.9% in December 2025, reducing Metronidazole input costs.
- Weak consumer demand (CPI 0.8%, retail sales 0.9%) in December 2025 limited Metronidazole pricing power.
- Elevated natural gas feedstock costs in Q4 2025 pressured Metronidazole production expenses.
For the Quarter Ending September 2025
Metronidazole Prices in North America
- In United States, the Metronidazole Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
- Metronidazole production costs faced upward pressure; PPI rose 2.6% year-over-year in August 2025, impacting supply.
- Demand for Metronidazole was influenced by weak overall chemical demand, despite increased new drug approvals in Q3 2025.
- The Metronidazole Price Forecast indicates continued upward pressure from anticipated production cost acceleration post-Q3 2025.
- Consumer Price Index increased 3.0% year-over-year in September 2025, impacting consumer affordability for healthcare spending.
- Retail sales increased 5.42% year-over-year in September 2025, supporting consumer purchasing power and healthcare access.
- Industrial production in September 2025 was 0.1% above year-earlier levels, suggesting weak broader industrial activity.
- A 4.3% unemployment rate in September 2025, alongside declining consumer confidence to 94.2, impacted discretionary spending.
Why did the price of Metronidazole change in September 2025 in North America?
- Production costs increased; PPI rose 2.6% year-over-year in August 2025, directly impacting Metronidazole supply costs.
- Overall chemical demand was weak in Q3 2025, but new drug approvals increased, creating mixed demand signals.
- Manufacturers accelerated inventory destocking while US chemical production levels declined in Q3 2025, affecting supply.
Metronidazole Prices in APAC
- In China, the Metronidazole Price Index fell quarter-over-quarter in Q3 2025, driven by weak consumer demand and falling producer prices.
- Metronidazole production costs experienced mixed trends, with ammonia and nitric acid strengthening in Q3 2025.
- Formaldehyde (methanol) feedstock costs declined significantly in Q3 2025, partially offsetting other production cost increases.
- Metronidazole demand outlook was supported by moderately increased pharmaceutical sector activity in Q3 2025.
- Overall chemical industry overcapacity persisted in Q3 2025, contributing to downward pressure on Metronidazole prices.
- China's Manufacturing Index contracted in September 2025, indicating reduced industrial activity affecting the market.
- Consumer confidence remained pessimistic in September 2025 (89.6 index), indirectly impacting healthcare spending and demand.
- Industrial production grew 6.5% in September 2025, supporting raw material availability for Metronidazole API.
- Retail sales increased 3.0% in September 2025, suggesting a supportive economic environment for healthcare expenditures.
Why did the price of Metronidazole change in September 2025 in APAC?
- Weak consumer demand, evidenced by CPI at -0.3% in September 2025, exerted downward pressure on prices.
- Falling producer prices, with PPI at -2.3% in September 2025, contributed to a challenging pricing environment.
- Contracting Manufacturing Index in September 2025 and persistent industry overcapacity impacted Metronidazole pricing.
Metronidazole Prices in Europe
- In Germany, the Metronidazole Price Index rose quarter-over-quarter in Q3 2025, influenced by rising manufacturing costs.
- Metronidazole production costs increased due to a 2.4% CPI rise in September 2025, despite a 1.7% PPI fall.
- European sulfuric acid export prices rose sharply in Q3 2025, contributing to higher Metronidazole production expenses.
- Metronidazole demand outlook remained stable, supported by moderate growth in Germany's pharmaceutical market in Q3 2025.
- European pharmaceutical export volumes strengthened in September 2025, boosting Metronidazole trade flows to the U.S.
- Tighter European chemical inventories and longer logistics cycles in September 2025 impacted Metronidazole supply dynamics.
- Germany's industrial production declined 1.0% in September 2025, indicating a contracting manufacturing sector affecting supply.
- The stable 6.3% unemployment rate in September 2025 supported consumer purchasing power and healthcare spending for Metronidazole.
Why did the price of Metronidazole change in September 2025 in Europe?
- Rising CPI by 2.4% in September 2025 increased Metronidazole manufacturing costs, pushing prices upward.
- Tighter European chemical inventories and longer logistics cycles in September 2025 constrained Metronidazole supply.
- Increased European sulfuric acid export prices in Q3 2025 contributed to higher Metronidazole production expenses.
